{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:05:30Z","timestamp":1785769530429,"version":"3.56.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,15]]},"DOI":"10.1093\/hmg\/ddl003","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T01:33:04Z","timestamp":1138671184000},"page":"839-851","source":"Crossref","is-referenced-by-count":71,"title":["Development and characterization of a hypomorphic Smith\u2013Lemli\u2013Opitz syndrome mouse model and efficacy of simvastatin therapy"],"prefix":"10.1093","volume":"15","author":[{"given":"Lina S.","family":"Correa-Cerro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Wassif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina F.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeva P.","family":"Munasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Fliesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,1,30]]},"reference":[{"key":"key\n\t\t\t\t20171012091902_DDL003C1","doi-asserted-by":"crossref","unstructured":"Porter, F.D. (2003) Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr. Opin. Pediatr., 15, 607\u2013613.","DOI":"10.1097\/00008480-200312000-00011"},{"key":"key\n\t\t\t\t20171012091902_DDL003C2","doi-asserted-by":"crossref","unstructured":"Smith, D.W., Lemli, L. and Opitz, J.M. (1964) A newly recognized syndrome of multiple congenital anomalies. J. Pediatr., 64, 210\u2013217.","DOI":"10.1016\/S0022-3476(64)80264-X"},{"key":"key\n\t\t\t\t20171012091902_DDL003C3","doi-asserted-by":"crossref","unstructured":"Kelley, R.I. and Hennekam, R.C. (2000) The Smith\u2013Lemli\u2013Opitz syndrome. J. Med. Genet., 37, 321\u2013335.","DOI":"10.1136\/jmg.37.5.321"},{"key":"key\n\t\t\t\t20171012091902_DDL003C4","doi-asserted-by":"crossref","unstructured":"Porter, F.D. (2002) Malformation syndromes due to inborn errors of cholesterol synthesis. J. Clin. Invest., 110, 715\u2013724.","DOI":"10.1172\/JCI0216386"},{"key":"key\n\t\t\t\t20171012091902_DDL003C5","doi-asserted-by":"crossref","unstructured":"Irons, M., Elias, E.R., Salen, G., Tint, G.S. and Batta, A.K. (1993) Defective cholesterol biosynthesis in Smith\u2013Lemli\u2013Opitz syndrome. Lancet, 341, 1414.","DOI":"10.1016\/0140-6736(93)90983-N"},{"key":"key\n\t\t\t\t20171012091902_DDL003C6","doi-asserted-by":"crossref","unstructured":"Tint, G.S., Irons, M., Elias, E.R., Batta, A.K., Frieden, R., Chen, T.S. and Salen, G. (1994) Defective cholesterol biosynthesis associated with the Smith\u2013Lemli\u2013Opitz syndrome. N. Engl. J. Med., 330, 107\u2013113.","DOI":"10.1056\/NEJM199401133300205"},{"key":"key\n\t\t\t\t20171012091902_DDL003C7","doi-asserted-by":"crossref","unstructured":"Wassif, C.A., Maslen, C., Kachilele-Linjewile, S., Lin, D., Linck, L.M., Connor, W.E., Steiner, R.D. and Porter, F.D. (1998) Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith\u2013Lemli\u2013Opitz syndrome. Am. J. Hum. Genet., 63, 55\u201362.","DOI":"10.1086\/301936"},{"key":"key\n\t\t\t\t20171012091902_DDL003C8","doi-asserted-by":"crossref","unstructured":"Fitzky, B.U., Witsch-Baumgartner, M., Erdel, M., Lee, J.N., Paik, Y.K., Glossmann, H., Utermann, G. and Moebius, F.F. (1998) Mutations in the Delta7-sterol reductase gene in patients with the Smith\u2013Lemli\u2013Opitz syndrome. Proc. Natl. Acad. Sci. USA, 95, 8181\u20138186.","DOI":"10.1073\/pnas.95.14.8181"},{"key":"key\n\t\t\t\t20171012091902_DDL003C9","doi-asserted-by":"crossref","unstructured":"Waterham, H.R., Wijburg, F.A., Hennekam, R.C., Vreken, P., Poll-The, B.T., Dorland, L., Duran, M., Jira, P.E., Smeitink, J.A., Wevers, R.A. et\u00a0al. (1998) Smith\u2013Lemli\u2013Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am. J. Hum. Genet., 63, 329\u2013338.","DOI":"10.1086\/301982"},{"key":"key\n\t\t\t\t20171012091902_DDL003C10","doi-asserted-by":"crossref","unstructured":"Correa-Cerro, L.S. and Porter, F.D. (2005) 3beta-hydroxysterol Delta7-reductase and the Smith\u2013Lemli\u2013Opitz syndrome. Mol. Genet. Metab., 84, 112\u2013126.","DOI":"10.1016\/j.ymgme.2004.09.017"},{"key":"key\n\t\t\t\t20171012091902_DDL003C11","doi-asserted-by":"crossref","unstructured":"Elias, E.R., Irons, M.B., Hurley, A.D., Tint, G.S. and Salen, G. (1997) Clinical effects of cholesterol supplementation in six patients with the Smith\u2013Lemli\u2013Opitz syndrome (SLOS). Am. J. Med. Genet., 68, 305\u2013310.","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X"},{"key":"key\n\t\t\t\t20171012091902_DDL003C12","doi-asserted-by":"crossref","unstructured":"Irons, M., Elias, E.R., Abuelo, D., Bull, M.J., Greene, C.L., Johnson, V.P., Keppen, L., Schanen, C., Tint, G.S. and Salen, G. (1997) Treatment of Smith\u2013Lemli\u2013Opitz syndrome: results of a multicenter trial. Am. J. Med. Genet., 68, 311\u2013314.","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<311::AID-AJMG12>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20171012091902_DDL003C13","doi-asserted-by":"crossref","unstructured":"Nwokoro, N.A. and Mulvihill, J.J. (1997) Cholesterol and bile acid replacement therapy in children and adults with Smith\u2013Lemli\u2013Opitz (SLO\/RSH) syndrome. Am. J. Med. Genet., 68, 315\u2013321.","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<315::AID-AJMG13>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20171012091902_DDL003C14","doi-asserted-by":"crossref","unstructured":"Linck, L.M., Lin, D.S., Flavell, D., Connor, W.E. and Steiner, R.D. (2000) Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith\u2013Lemli\u2013Opitz syndrome. Am. J. Med. Genet., 93, 360\u2013365.","DOI":"10.1002\/1096-8628(20000828)93:5<360::AID-AJMG4>3.0.CO;2-P"},{"key":"key\n\t\t\t\t20171012091902_DDL003C15","doi-asserted-by":"crossref","unstructured":"Starck, L., Lovgren-Sandblom, A. and Bjorkhem, I. (2002) Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith\u2013Lemli\u2013Opitz syndrome. J. Intern. Med., 252, 314\u2013321.","DOI":"10.1046\/j.1365-2796.2002.01037.x"},{"key":"key\n\t\t\t\t20171012091902_DDL003C16","doi-asserted-by":"crossref","unstructured":"Merkens, L.S., Connor, W.E., Linck, L.M., Lin, D.S., Flavell, D.P. and Steiner, R.D. (2004) Effects of dietary cholesterol on plasma lipoproteins in Smith\u2013Lemli\u2013Opitz syndrome. Pediatr. Res., 56, 726\u2013732.","DOI":"10.1203\/01.PDR.0000141522.14177.4F"},{"key":"key\n\t\t\t\t20171012091902_DDL003C17","unstructured":"Jurevics, H.A., Kidwai, F.Z. and Morell, P. (1997) Sources of cholesterol during development of the rat fetus and fetal organs. J. Lipid Res., 38, 723\u2013733."},{"key":"key\n\t\t\t\t20171012091902_DDL003C18","doi-asserted-by":"crossref","unstructured":"Pardridge, W.M. and Mietus, L.J. (1980) Palmitate and cholesterol transport through the blood\u2013brain barrier. J. Neurochem., 34, 463\u2013466.","DOI":"10.1111\/j.1471-4159.1980.tb06621.x"},{"key":"key\n\t\t\t\t20171012091902_DDL003C19","unstructured":"Sikora, D.M., Ruggiero, M., Petit-Kekel, K., Merkens, L.S., Connor, W.E. and Steiner, R.D. (2004) Cholesterol supplementation does not improve developmental progress in Smith\u2013Lemli\u2013Opitz syndrome. J. Pediatr., 144, 783\u2013791."},{"key":"key\n\t\t\t\t20171012091902_DDL003C20","unstructured":"Jira, P.E., Wevers, R.A., de Jong, J., Rubio-Gozalbo, E., Janssen-Zijlstra, F.S., van Heyst, A.F., Sengers, R.C. and Smeitink, J.A. (2000) Simvastatin. A new therapeutic approach for Smith\u2013Lemli\u2013Opitz syndrome. J. Lipid Res., 41, 1339\u20131346."},{"key":"key\n\t\t\t\t20171012091902_DDL003C21","doi-asserted-by":"crossref","unstructured":"Starck, L., Lovgren-Sandblom, A. and Bjorkhem, I. (2002) Simvastatin treatment in the SLO syndrome: a safe approach? Am. J. Med. Genet., 113, 183\u2013189.","DOI":"10.1002\/ajmg.10722"},{"key":"key\n\t\t\t\t20171012091902_DDL003C22","doi-asserted-by":"crossref","unstructured":"Saheki, A., Terasaki, T., Tamai, I. and Tsuji, A. (1994) In vivo and in vitro blood\u2013brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm. Res., 11, 305\u2013311.","DOI":"10.1023\/A:1018975928974"},{"key":"key\n\t\t\t\t20171012091902_DDL003C23","doi-asserted-by":"crossref","unstructured":"Wassif, C.A., Krakowiak, P.A., Wright, B.S., Gewandter, J.S., Sterner, A.L., Javitt, N., Yergey, A.L. and Porter, F.D. (2005) Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith\u2013Lemli\u2013Opitz syndrome fibroblasts. Mol. Genet. Metab., 85, 96\u2013107.","DOI":"10.1016\/j.ymgme.2004.12.009"},{"key":"key\n\t\t\t\t20171012091902_DDL003C24","doi-asserted-by":"crossref","unstructured":"Wassif, C.A., Zhu, P., Kratz, L., Krakowiak, P.A., Battaile, K.P., Weight, F.F., Grinberg, A., Steiner, R.D., Nwokoro, N.A., Kelley, R.I. et\u00a0al. (2001) Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH\/Smith\u2013Lemli\u2013Opitz syndrome. Hum. Mol. Genet., 10, 555\u2013564.","DOI":"10.1093\/hmg\/10.6.555"},{"key":"key\n\t\t\t\t20171012091902_DDL003C25","doi-asserted-by":"crossref","unstructured":"Fitzky, B.U., Moebius, F.F., Asaoka, H., Waage-Baudet, H., Xu, L., Xu, G., Maeda, N., Kluckman, K., Hiller, S., Yu, H. et\u00a0al. (2001) 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith\u2013Lemli\u2013Opitz\/RSH syndrome. J. Clin. Invest., 108, 905\u2013915.","DOI":"10.1172\/JCI200112103"},{"key":"key\n\t\t\t\t20171012091902_DDL003C26","doi-asserted-by":"crossref","unstructured":"Caldas, H., Cunningham, D., Wang, X., Jiang, F., Humphries, L., Kelley, R.I. and Herman, G.E. (2005) Placental defects are associated with male lethality in bare patches and striated embryos deficient in the NAD(P)H steroid dehydrogenase-like (NSDHL) enzyme. Mol. Genet. Metab., 84, 48\u201360.","DOI":"10.1016\/j.ymgme.2004.08.007"},{"key":"key\n\t\t\t\t20171012091902_DDL003C27","doi-asserted-by":"crossref","unstructured":"Lee, J.N., Bae, S.H. and Paik, Y.K. (2002) Structure and alternative splicing of the rat 7-dehydrocholesterol reductase gene. Biochim. Biophys. Acta, 1576, 148\u2013156.","DOI":"10.1016\/S0167-4781(02)00285-3"},{"key":"key\n\t\t\t\t20171012091902_DDL003C28","doi-asserted-by":"crossref","unstructured":"Horton, J.D., Goldstein, J.L. and Brown, M.S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest., 109, 1125\u20131131.","DOI":"10.1172\/JCI0215593"},{"key":"key\n\t\t\t\t20171012091902_DDL003C29","doi-asserted-by":"crossref","unstructured":"Woollett, L.A. (2001) The origins and roles of cholesterol and fatty acids in the fetus. Curr. Opin. Lipidol., 12, 305\u2013312.","DOI":"10.1097\/00041433-200106000-00010"},{"key":"key\n\t\t\t\t20171012091902_DDL003C30","doi-asserted-by":"crossref","unstructured":"Krakowiak, P.A., Wassif, C.A., Kratz, L., Cozma, D., Kovarova, M., Harris, G., Grinberg, A., Yang, Y., Hunter, A.G., Tsokos, M. et\u00a0al. (2003) Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. Hum. Mol. Genet., 12, 1631\u20131641.","DOI":"10.1093\/hmg\/ddg172"},{"key":"key\n\t\t\t\t20171012091902_DDL003C31","doi-asserted-by":"crossref","unstructured":"Brunetti-Pierri, N., Corso, G., Rossi, M., Ferrari, P., Balli, F., Rivasi, F., Annunziata, I., Ballabio, A., Russo, A.D., Andria, G. et\u00a0al. (2002) Lathosterolosis, a novel multiple-malformation\/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase. Am. J. Hum. Genet., 71, 952\u2013958.","DOI":"10.1086\/342668"},{"key":"key\n\t\t\t\t20171012091902_DDL003C32","doi-asserted-by":"crossref","unstructured":"Rossi, M., Vajro, P., Iorio, R., Battagliese, A., Brunetti-Pierri, N., Corso, G., Di Rocco, M., Ferrari, P., Rivasi, F., Vecchione, R. et\u00a0al. (2005) Characterization of liver involvement in defects of cholesterol biosynthesis: long-term follow-up and review. Am. J. Med. Genet. A, 132, 144\u2013151.","DOI":"10.1002\/ajmg.a.30426"},{"key":"key\n\t\t\t\t20171012091902_DDL003C33","doi-asserted-by":"crossref","unstructured":"FitzPatrick, D.R., Keeling, J.W., Evans, M.J., Kan, A.E., Bell, J.E., Porteous, M.E., Mills, K., Winter, R.M. and Clayton, P.T. (1998) Clinical phenotype of desmosterolosis. Am. J. Med. Genet., 75, 145\u2013152.","DOI":"10.1002\/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S"},{"key":"key\n\t\t\t\t20171012091902_DDL003C34","doi-asserted-by":"crossref","unstructured":"Wechsler, A., Brafman, A., Shafir, M., Heverin, M., Gottlieb, H., Damari, G., Gozlan-Kelner, S., Spivak, I., Moshkin, O., Fridman, E. et\u00a0al. (2003) Generation of viable cholesterol-free mice. Science, 302, 2087.","DOI":"10.1126\/science.1090776"},{"key":"key\n\t\t\t\t20171012091902_DDL003C35","doi-asserted-by":"crossref","unstructured":"Shackleton, C.H., Roitman, E. and Kelley, R. (1999) Neonatal urinary steroids in Smith\u2013Lemli\u2013Opitz syndrome associated with 7-dehydrocholesterol reductase deficiency. Steroids, 64, 481\u2013490.","DOI":"10.1016\/S0039-128X(99)00022-7"},{"key":"key\n\t\t\t\t20171012091902_DDL003C36","doi-asserted-by":"crossref","unstructured":"Shackleton, C., Roitman, E., Guo, L.W., Wilson, W.K. and Porter, F.D. (2002) Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-delta7-reductase deficiency (Smith\u2013Lemli\u2013Opitz syndrome). J. Steroid Biochem. Mol. Biol., 82, 225\u2013232.","DOI":"10.1016\/S0960-0760(02)00155-3"},{"key":"key\n\t\t\t\t20171012091902_DDL003C37","doi-asserted-by":"crossref","unstructured":"Wassif, C.A., Yu, J., Cui, J., Porter, F.D. and Javitt, N.B. (2003) 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith\u2013Lemli\u2013Opitz syndrome: a novel metabolic pathway. Steroids, 68, 497\u2013502.","DOI":"10.1016\/S0039-128X(03)00090-4"},{"key":"key\n\t\t\t\t20171012091902_DDL003C38","doi-asserted-by":"crossref","unstructured":"Marcos, J., Guo, L.W., Wilson, W.K., Porter, F.D. and Shackleton, C. (2004) The implications of 7-dehydrosterol-7-reductase deficiency (Smith\u2013Lemli\u2013Opitz syndrome) to neurosteroid production. Steroids, 69, 51\u201360.","DOI":"10.1016\/j.steroids.2003.09.013"},{"key":"key\n\t\t\t\t20171012091902_DDL003C39","doi-asserted-by":"crossref","unstructured":"Javitt, N.B. (2004) Oxysteroids: a new class of steroids with autocrine and paracrine functions. Trends Endocrinol. Metab., 15, 393\u2013397.","DOI":"10.1016\/j.tem.2004.08.009"},{"key":"key\n\t\t\t\t20171012091902_DDL003C40","doi-asserted-by":"crossref","unstructured":"Lanoue, L., Dehart, D.B., Hinsdale, M.E., Maeda, N., Tint, G.S. and Sulik, K.K. (1997) Limb, genital, CNS, and facial malformations result from gene\/environment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog. Am. J. Med. Genet., 73, 24\u201331.","DOI":"10.1002\/(SICI)1096-8628(19971128)73:1<24::AID-AJMG6>3.0.CO;2-P"},{"key":"key\n\t\t\t\t20171012091902_DDL003C41","unstructured":"Shefer, S., Salen, G., Honda, A., Batta, A.K., Nguyen, L.B., Tint, G.S., Ioannou, Y.A. and Desnick, R. (1998) Regulation of rat hepatic 3beta-hydroxysterol delta7-reductase: substrate specificity, competitive and non-competitive inhibition, and phosphorylation\/dephosphorylation. J. Lipid Res., 39, 2471\u20132476."},{"key":"key\n\t\t\t\t20171012091902_DDL003C42","doi-asserted-by":"crossref","unstructured":"Ness, G.C. and Gertz, K.R. (2004) Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol. Exp. Biol. Med. (Maywood), 229, 412\u2013416.","DOI":"10.1177\/153537020422900509"},{"key":"key\n\t\t\t\t20171012091902_DDL003C43","doi-asserted-by":"crossref","unstructured":"Dietschy, J.M., Turley, S.D. and Spady, D.K. (1993) Role of liver in the maintenance of cholesterol and low-density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res., 34, 1637\u20131659.","DOI":"10.1016\/S0022-2275(20)35728-X"},{"key":"key\n\t\t\t\t20171012091902_DDL003C44","doi-asserted-by":"crossref","unstructured":"Tierney, E., Nwokoro, N.A., Porter, F.D., Freund, L.S., Ghuman, J.K. and Kelley, R.I. (2001) Behavior phenotype in the RSH\/Smith\u2013Lemli\u2013Opitz syndrome. Am. J. Med. Genet., 98, 191\u2013200.","DOI":"10.1002\/1096-8628(20010115)98:2<191::AID-AJMG1030>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20171012091902_DDL003C45","doi-asserted-by":"crossref","unstructured":"Wyatt, A.W., Steinert, J.R. and Mann, G.E. (2004) Modulation of the l-arginine\/nitric oxide signalling pathway in vascular endothelial cells. Biochem. Soc. Symp., 71, 143\u2013156.","DOI":"10.1042\/bss0710143"},{"key":"key\n\t\t\t\t20171012091902_DDL003C46","doi-asserted-by":"crossref","unstructured":"Ness, G.C., Zhao, Z. and Lopez, D. (1996) Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation. Arch. Biochem. Biophys., 325, 242\u2013248.","DOI":"10.1006\/abbi.1996.0030"},{"key":"key\n\t\t\t\t20171012091902_DDL003C47","unstructured":"Bucher, N.L. and McGarrahan, K. (1956) The biosynthesis of cholesterol from acetate-1-C14 by cellular fractions of rat liver. J. Biol. Chem., 222, 1\u201315."},{"key":"key\n\t\t\t\t20171012091902_DDL003C48","doi-asserted-by":"crossref","unstructured":"Aaronson, S.A. and Todaro, G.J. (1968) Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J. Cell Physiol., 72, 141\u2013148.","DOI":"10.1002\/jcp.1040720208"},{"key":"key\n\t\t\t\t20171012091902_DDL003C49","unstructured":"Cham, B.E. and Knowles, B.R. (1976) A solvent system for delipidation of plasma or serum without protein precipitation. J. Lipid Res., 17, 176\u2013181."},{"key":"key\n\t\t\t\t20171012091902_DDL003C50","unstructured":"Paxinos, G. and Keith, B.J.F. (1997) The Mouse Brain in Stereotaxic Coordinates. 2nd edition. Academic Press, USA."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/15\/6\/839\/17243160\/ddl003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:17:41Z","timestamp":1683368261000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/15\/6\/839\/582327\/Development-and-characterization-of-a-hypomorphic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,30]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,1,30]]},"published-print":{"date-parts":[[2006,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddl003","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,3,15]]},"published":{"date-parts":[[2006,1,30]]}}}